Total Payments
$2,873
2024 Payments
$491.27
Companies
26
Transactions
155
Medicare Patients
8,601
Medicare Billing
$875,640
Payment Breakdown by Category
Food & Beverage$2,873 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,873 | 155 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $533.65 | 38 | $0 (2023) |
| Novo Nordisk Inc | $476.83 | 9 | $0 (2024) |
| Boston Scientific Corporation | $357.37 | 15 | $0 (2024) |
| Amgen Inc. | $241.92 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $180.47 | 14 | $0 (2024) |
| PFIZER INC. | $109.47 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $102.60 | 7 | $0 (2024) |
| AtriCure, Inc. | $96.06 | 1 | $0 (2017) |
| Amarin Pharma Inc. | $91.81 | 7 | $0 (2021) |
| Kestra Medical Technology Services, Inc. | $90.45 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.27 | 22 | Boston Scientific Corporation ($231.19) |
| 2023 | $358.82 | 22 | Boston Scientific Corporation ($85.99) |
| 2022 | $428.73 | 13 | Novo Nordisk Inc ($249.66) |
| 2021 | $352.25 | 17 | Novo Nordisk Inc ($154.22) |
| 2020 | $317.52 | 23 | Janssen Pharmaceuticals, Inc ($113.53) |
| 2019 | $458.93 | 33 | Janssen Pharmaceuticals, Inc ($292.48) |
| 2018 | $290.80 | 18 | Medtronic Vascular, Inc. ($90.16) |
| 2017 | $174.45 | 7 | AtriCure, Inc. ($96.06) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 7 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2017 | AtriCure, Inc. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS (Device) | Food and Beverage | Cash or cash equivalent | $96.06 | General |
| Category: CARDIOTHORACIC | ||||||
| 08/30/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,372 | 1,782 | $541,686 | $170,463 |
| 2022 | 18 | 1,740 | 2,172 | $654,240 | $198,058 |
| 2021 | 20 | 2,660 | 3,572 | $739,365 | $236,183 |
| 2020 | 20 | 2,829 | 4,007 | $853,920 | $270,936 |
Total Patients
8,601
Total Services
11,533
Medicare Billing
$875,640
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 184 | 261 | $41,760 | $26,286 | 62.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 65 | 65 | $97,500 | $25,377 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 160 | 160 | $175,175 | $25,222 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 224 | $35,840 | $22,152 | 61.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 101 | $30,300 | $14,655 | 48.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 48 | 192 | $13,150 | $8,238 | 62.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 116 | $12,760 | $7,641 | 59.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 48 | $10,670 | $7,235 | 67.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 65 | 65 | $8,111 | $6,045 | 74.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 102 | 103 | $36,050 | $5,587 | 15.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 92 | 95 | $26,125 | $5,443 | 20.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $6,100 | $3,090 | 50.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 148 | 209 | $15,675 | $2,462 | 15.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $4,950 | $2,442 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 20 | $4,500 | $2,291 | 50.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,965 | $1,925 | 48.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,500 | $1,698 | 48.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 15 | 15 | $4,200 | $1,347 | 32.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 12 | $7,200 | $1,108 | 15.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 12 | 12 | $2,280 | $179.76 | 7.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 15 | 15 | $1,875 | $38.85 | 2.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 107 | 107 | $160,500 | $44,539 | 27.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 170 | 171 | $188,100 | $27,364 | 14.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 144 | 156 | $46,800 | $24,686 | 52.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 140 | 204 | $32,640 | $17,208 | 52.7% |
About Dr. Arpit Patel, M.D
Dr. Arpit Patel, M.D is a Cardiovascular Disease healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2012. The National Provider Identifier (NPI) number assigned to this provider is 1194074591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arpit Patel, M.D has received a total of $2,873 in payments from pharmaceutical and medical device companies, with $491.27 received in 2024. These payments were reported across 155 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,873).
As a Medicare-enrolled provider, Patel has provided services to 8,601 Medicare beneficiaries, totaling 11,533 services with total Medicare billing of $875,640. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Piscataway, NJ
- Active Since 08/31/2012
- Last Updated 06/05/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1194074591
Products in Payments
- XARELTO (Drug) $533.65
- Rybelsus (Drug) $249.66
- WATCHMAN FLX (Device) $231.19
- Repatha (Biological) $200.88
- ELIQUIS (Drug) $166.37
- RYBELSUS (Drug) $139.75
- VERQUVO (Drug) $102.60
- WATCHMAN (Device) $101.75
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS (Device) $96.06
- Vascepa (Drug) $91.81
- Assure WCD (Device) $90.45
- Resolute (Device) $90.16
- LifeVest (Device) $85.74
- CAMZYOS (Drug) $81.62
- Wegovy (Drug) $58.04
- PRALUENT (Drug) $53.72
- ENTRESTO (Drug) $51.60
- BRILINTA (Drug) $51.57
- Corlanor (Drug) $41.04
- FUROSCIX (Drug) $34.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.